MDAI vs GXAI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

MDAI

46.9
AI Score
VS
MDAI Wins

GXAI

46.7
AI Score

Investment Advisor Scores

MDAI

47score
Recommendation
BUY

GXAI

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MDAI GXAI Winner
Forward P/E 52.356 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -30.4% 1337.3% GXAI
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 46.9/100 46.7/100 MDAI
Profit Margin -65.5% -64.8% GXAI
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD MDAI

Relative Price Performance (Last 90 Days)

MDAI 1M: +6.1% · 3M: -11.2% GXAI 1M: -31.7% · 3M: -53.5%

Current Technical Phase

MDAI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 55.8 · Price: $1.66

GXAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.6%), weak momentum, RSI 27

RSI (14): 27.2 · Price: $0.52

Fundamentals Snapshot

Metric MDAI GXAI
Market Cap — —
Forward P/E -5.4 -1.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.3% 13.4%
Gross Margin 0.4% 1.0%
Operating Margin -1.2% -0.8%
EPS -0.32 -0.48
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MDAI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.